AOD-9604
Fine-tuning fat loss without appetite change.
SC injection (near fat deposits or systemic) — 300 mcg SC daily (historically); 300 mcg SC daily referenced in Metabolic Reset Archetype protocol
What It Is
AOD-9604 is a modified fragment of human growth hormone (amino acids 176–191) engineered to retain GH's fat-burning (lipolytic) activity without its growth/trophic effects.
Mechanism
AOD-9604 triggers fat breakdown primarily via the beta-3 adrenergic pathway in adipose tissue. It enhances lipolysis, inhibits new fat formation, and does so without raising IGF-1 or affecting blood sugar. It essentially tells fat cells to release fat for fuel while not engaging the broader anabolic signals of GH. Recent research also suggests AOD-9604 may aid cartilage repair and joint healing, likely through localized growth factor stimulation and anti-inflammatory action.
How Dr. Emer Uses It
The Emer Method uses AOD-9604 in stubborn fat and injury repair contexts. It can be injected subcutaneously near resistant fat deposits (some use it "mesotherapy"-style) or systemically. Because AOD-9604 alone won't cause dramatic weight loss, Emer's protocols stack it with diet, GLP-1, or tesofensine if appetite suppression is needed, and exercise to capitalize on increased lipolytic sensitivity. It is also included in a "joint recovery stack" for patients with knee pain to reduce pain and improve function alongside PRP or exosome injections.
Key Benefits
- ✓Triggers lipolysis via the beta-3 adrenergic pathway in adipose tissue
- ✓Inhibits new fat formation without affecting IGF-1 or blood glucose
- ✓Fine-tunes fat loss while preserving appetite for muscle-building nutrition
- ✓May aid cartilage repair and joint healing via localized growth factor stimulation
- ✓No growth/trophic side effects (no IGF-1 elevation, no dysglycemia)
- ✓Complements GLP-1 therapy to target stubborn subcutaneous fat deposits
Pairs Well With
Used In Programs
Safety & Considerations
Risk profile is excellent: no significant IGF-1 elevation, no dysglycemia. It is one of few peptides explicitly classified by the FDA as a low-risk substance, allowed in supplements in some countries. Side effects are minimal, typically just injection site redness. In rare cases, if dosed high, transient headaches or flu-like aches have been noted, possibly from liberated fatty acids.
Begin Your RECODEX™ Protocol
All peptide therapies are prescribed under direct medical supervision.
Book a Consultation
